文献速递临床试验与 GCP医学人工智能与信息学

引导式抗菌药物管理提示改善肺炎抗生素选择:INSPIRE随机临床试验

Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial.
PubMed 文献 · JAMA · 2024-01-01

INSPIRE集群随机试验在59家美国社区医院比较计算机化医嘱录入(CPOE)管理提示与常规管理对非重症肺炎成人初始抗生素选择的影响。提示组经验性广谱抗生素治疗天数较常规组降低28.4%(率比0.72,95%CI 0.66-0.78;P<.001),ICU转入天数和住院时长无显著差异。

要点

  • CPOE提示组经验性广谱抗生素治疗天数较常规组降低28.4%(率比0.72,95%CI 0.66-0.78;P<.001)。
  • 常规组与CPOE提示组平均ICU转入天数(6.5 vs 7.1天)和住院时长(6.8 vs 7.1天)无显著差异。
  • 提示内容为对多药耐药菌感染估计绝对风险低于10%的患者推荐标准谱抗生素。

核心结论

  • 在非ICU住院的肺炎成人中,使用教育、反馈和CPOE提示(对多药耐药菌感染低风险患者推荐标准谱抗生素)的医院,经验性广谱抗生素使用显著低于常规管理组,住院时长和ICU转入天数无变化。

研究设计与样本

  • 集群随机临床试验,纳入59家美国社区医院,比较CPOE管理组合(教育、反馈和基于多药耐药菌风险的实时CPOE提示;29家医院)与常规管理(30家医院)。
  • 研究对象为住院肺炎的非重症成人(≥18岁),基线期18个月(2017年4月1日至2018年9月30日),干预期15个月(2019年4月1日至2020年6月30日)。
  • 共96451例肺炎住院成人,基线期51671例,干预期44780例;患者平均(SD)年龄68.1(17.0)岁,48.1%为男性,Elixhauser合并症计数中位数(IQR)为4(2-6)。

主要发现

  • 与常规管理相比,CPOE提示组经验性广谱抗生素治疗天数降低28.4%(率比0.72,95%CI 0.66-0.78;P<.001)。
  • 常规组与CPOE提示组平均ICU转入天数(6.5 vs 7.1天)和住院时长(6.8 vs 7.1天)无显著差异。

关键数值与推荐

  • CPOE提示推荐:对经验性治疗期被开具广谱抗生素且多药耐药菌肺炎估计绝对风险低于10%的患者,推荐标准谱抗生素。
  • 主要结局为住院前3天(经验性治疗期)广谱抗生素治疗天数;次要结局包括经验性万古霉素和抗假单胞菌治疗天数。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Pneumonia is the most common infection requiring hospitalization and is a major reason for overuse of extended-spectrum antibiotics. Despite low risk of multidrug-resistant organism (MDRO) infection, clinical uncertainty often drives initial antibiotic selection. Strategies to limit empiric antibiotic overuse for patients with pneumonia are needed. OBJECTIVE: To evaluate whether computerized provider order entry (CPOE) prompts providing patient- and pathogen-specific MDRO infection risk estimates could reduce empiric extended-spectrum antibiotics for non-critically ill patients admitted with pneumonia. DESIGN, SETTING, AND PARTICIPANTS: Cluster-randomized trial in 59 US community hospitals comparing the effect of a CPOE stewardship bundle (education, feedback, and real-time MDRO risk-based CPOE prompts; n = 29 hospitals) vs routine stewardship (n = 30 hospitals) on antibiotic selection during the first 3 hospital days (empiric period) in non-critically ill adults (≥18 years) hospitalized with pneumonia. There was an 18-month baseline period from April 1, 2017, to September 30, 2018, and a 15-month intervention period from April 1, 2019, to June 30, 2020. INTERVENTION: CPOE prompts recommending standard-spectrum antibiotics in patients ordered to receive extended-spectrum antibiotics during the empiric period who have low estimated absolute risk (<10%) of MDRO pneumonia, coupled with feedback and education. MAIN OUTCOMES AND MEASURES: The primary outcome was empiric (first 3 days of hospitalization) extended-spectrum antibiotic days of therapy. Secondary outcomes included empiric vancomycin and antipseudomonal days of therapy and safety outcomes included days to intensive care unit (ICU) transfer and hospital length of stay. Outcomes compared differences between baseline and intervention periods across strategies. RESULTS: Among 59 hospitals with 96 451 (51 671 in the baseline period and 44 780 in the intervention period) adult patients admitted with pneumonia, the mean (SD) age of patients was 68.1 (17.0) years, 48.1% were men, and the median (IQR) Elixhauser comorbidity count was 4 (2-6). Compared with routine stewardship, the group using CPOE prompts had a 28.4% reduction in empiric extended-spectrum days of therapy (rate ratio, 0.72 [95% CI, 0.66-0.78]; P < .001). Safety outcomes of mean days to ICU transfer (6.5 vs 7.1 days) and hospital length of stay (6.8 vs 7.1 days) did not differ significantly between the routine and CPOE intervention groups. CONCLUSIONS AND RELEVANCE: Empiric extended-spectrum antibiotic use was significantly lower among adults admitted with pneumonia to non-ICU settings in hospitals using education, feedback, and CPOE prompts recommending standard-spectrum antibiotics for patients at low risk of MDRO infection, compared with routine stewardship practices. Hospital length of stay and days to ICU transfer were unchanged. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03697070.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Gohil SK, Septimus E, Kleinman K, et al. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial. JAMA. 2024. PMID: 38639729. doi:10.1001/jama.2024.6248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。